25 results
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
volatility (%)
Risk-free interest rate (%)
Expected life of warrants (years)
Market price of ADS ($)
Model used
Black-Scholes
12. Shareholders’ Equity … of the Company’s ADSs for the Options that were in-the-money at March 31, 2024.
The fair value of each Option is estimated on the date of grant using the Black
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
Hispanic or Latinx
Native Hawaiian or Pacific
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
(or purchase) Company shares without the restrictions of trading windows and black-out periods, even when there is undisclosed material information … about the Company, and only during a trading window period outside of the trading black-out period, and the person who entered into the Trading Plan
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
Sensitivity of the input to fair value
Warrant liability related to the private placement warrants
Black- Scholes model
Expected volatility
2023: n/a
2022 … :
December 31,
Expected volatility (%)
Risk-free interest rate (%)
Expected life of warrants (years)
Market price of ADS ($)
Model used
Black-Scholes
13
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
7 Sep 23
Current report (foreign)
7:37am
June 30, 2023, were valued using the Black-Scholes model with the following weighted average inputs: expected volatility of
98.06%; risk free … the six months ended June 30, 2023 were valued using the Black-Scholes model with the following inputs: expected volatility of
97.94%; risk free
6-K
EX-99.1
1ordu6
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.1
x5j2b6x7t5iytxxp
2 Nov 21
Current report (foreign)
4:16pm
6-K
EX-99.2
g4z7ki0
29 Sep 20
Current report (foreign)
7:08am
6-K
04mujx6un
16 Jun 20
Current report (foreign)
4:13pm
6-K
EX-10.1
mblwxuvmgm3wg9pa
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
6-K
EX-10.4
u1af9
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
F-1/A
oy0ql jks
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
dvo5qr2a 76
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
4n1u wh20g7
17 Sep 19
Current report (foreign)
8:06am
20-F
3ie944sr1j ukvhd5ut5
29 Apr 19
Annual report (foreign)
4:59pm
6-K
qqig2 usk
29 Apr 19
Current report (foreign)
12:09pm
425
v66 klay34xmumsfr2i
12 Mar 19
Business combination disclosure
9:27am